Skip to main content

A clearer way to understand peptides.

Learn well · Choose thoughtfully

A clearer way to understand peptides.

Explore the research, understand which product category you are reading about, and know what to look for before comparing options.

This week’s guide Copper Peptides in Skincare: How to Read the Evidence →

  • Sources beside every claim
  • Evidence stage on every guide
  • Commercial ties disclosed

Five categories. Different questions.

Evidence and product status don’t travel between categories — so neither do our conclusions.

  • 005 guides

    Foundations

    Category literacy, study reading, and how we evaluate.

    No commercial links
  • 013 guides

    Skin & Topical

    Finished cosmetic products. Evidence for a topical formula is not transferred to injected forms of the same molecule.

    Product reviews · no paid links
  • 023 guides

    Collagen & Nutrition

    Collagen and related consumer products. The formula and the measured outcome are always stated together.

    Product reviews · no paid links
  • 033 guides

    Therapeutics Explained

    Approved treatments, investigational drugs, and regulatory news — explained, never sold.

    Education only · no sales links
  • 047 guides

    Research Peptides

    Study literature and supplier documentation. No human-use guidance or protocols.

    Supplier links off

The reading room

View all guides →

Editor’s pick · Start here

What Are Peptides? Start with the Product Category

The same word covers skincare ingredients, prescription medicines, supplements and research materials. The category decides which evidence applies.

  • Four questions to ask before reading any claim
  • A reading path through the launch guides
  • FoundationsGuide

    How to Read a Peptide Study

    Cells, animals or people; which form and route; what was measured; who paid. The questions to ask before a study result means anything to you.

    Literacy guide · no evidence ratingChecked

Our approach

Clear sources. Room for uncertainty.

Read our standards →

What we know

The short answer first, tied to the product category and form it applies to.

What remains uncertain

Limits sit next to the claim they qualify — not in a footnote.

Sources, checked

Every guide lists its sources, a last-checked date, and a correction path.

  • Human clinical evidenceControlled trials in people, for this specific claim.
  • Early human evidenceSmall, short, or uncontrolled human studies.
  • PreclinicalCell or animal studies only.
  • Mixed / insufficientConflicting results or too little to judge.

Before you compare

Look beyond the label.

Desk reviews of documentation and policies. We say what we checked — and what we didn’t.

All reviews →

Recently checked

What changed, and why.

An updated date means something was re-checked. We log what it was.

All research updates →
  • Approved, Compounded, and Unapproved: Understanding the TermsAdded HHS's October 30, 2026 draft enforcement-discretion policy for six peptides and why it is neither a 503A listing nor an approval; compounding statuses re-checked.
  • BPC-157 Research: Study Types and Open QuestionsAdded HHS's October 30, 2026 draft enforcement-discretion policy for 503A compounding of BPC-157 acetate, its conditions and its account of the committee vote; status re-checked.
  • MOTS-c: What Is Being Studied?Added HHS's October 30, 2026 draft enforcement-discretion policy for 503A compounding of MOTS-c acetate, its conditions and its account of the committee vote; status re-checked.
  • MOTS-c: What Is Being Studied?Removed a short-answer sentence saying a placebo-controlled trial began recruiting in 2026; it described the registry record we do not count.